Skip to main content

Table 1 Demographics of enrolled patients

From: Left atrial wall thickness and its relationship with reconnection after pulmonary vein isolation in patients with atrial fibrillation evaluated using a three-dimensional wall thickness map

 

Total (n = 79)

Age (years)

60 ± 9.4

Men

65 (82%)

Height (cm)

168 ± 8.41

Weight (kg)

70.0 ± 10.7

Body mass index (kg/m2)

24.7 ± 2.47

Paroxysmal AF

50 (63%)

LV ejection fraction (%)

58 ± 6.9

LA volume index (ml/m2)

45 ± 16

Heart failure

11 (14%)

Hypertension

35 (44%)

Diabetes mellitus

16 (20%)

Cerebral infarction/transient ischemic attack

5 (6.3%)

Chronic kidney disease

9 (11%)

Medications

 ACEI/ARB

20 (25%)

 Beta blocker

22 (28%)

 Calcium channel blocker

24 (30%)

 Oral anticoagulants

79 (100%)

  Warfarin

26 (33%)

  NOAC

53 (67%)

 Antiarrhythmic drugs

71 (90%)

  Class IC

49 (62%)

  Class III

22 (28%)

  1. ACEI angiotensin converting enzyme inhibitor, AF atrial fibrillation, ARB angiotensin II receptor blocker, LA left atrium, LV left ventricle, NOAC non-vitamin K antagonist oral anticoagulants